AVRICORE HEALTH INC (AVCR.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:AVCR - CA0545211090 - Common Stock
AVCR.CA Key Statistics, Chart & Performance
The current stock price of AVCR.CA is 0.05 CAD. In the past month the price decreased by -28.57%. In the past year, price decreased by -16.67%.
AVCR.CA Latest News, Press Relases and Analysis
AVCR.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VHI.CA | VITALHUB CORP | 92.9 | 585.27M | ||
| NURS.CA | HYDREIGHT TECHNOLOGIES INC | N/A | 249.69M | ||
| KDA.CA | KDA GROUP INC | N/A | 49.58M | ||
| ADK.CA | DIAGNOS INC | N/A | 30.90M | ||
| EKG.CA | CARDIOCOMM SOLUTIONS INC | N/A | 1.97M |
Related stock screener links
About AVCR.CA
Company Profile
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
Company Info
AVRICORE HEALTH INC
1120 - 789 West Pender Street
Vancouver BRITISH COLUMBIA V7X 1H7 CA
CEO: Hector Bremner
Employees: 0
Phone: 16047738943
AVRICORE HEALTH INC / AVCR.CA FAQ
What does AVCR do?
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
What is the current price of AVCR stock?
The current stock price of AVCR.CA is 0.05 CAD.
What is the dividend status of AVRICORE HEALTH INC?
AVCR.CA does not pay a dividend.
How is the ChartMill rating for AVRICORE HEALTH INC?
AVCR.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy AVCR stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVCR.CA.
When does AVRICORE HEALTH INC (AVCR.CA) report earnings?
AVRICORE HEALTH INC (AVCR.CA) will report earnings on 2025-11-27.
AVCR.CA Technical Analysis
AVCR.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA. AVCR.CA has a great financial health rating, but its profitability evaluates not so good.
AVCR.CA Financial Highlights
Over the last trailing twelve months AVCR.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -15200% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.63% | ||
| ROE | -88.09% | ||
| Debt/Equity | 0 |